AttributesValues
rdf:type
Description
  • Díky svému terapeutickému účinku lze považovat K oximy za slibné oximy pro antidotní terapii akutní otravy tabunem, zatímco oxim HI-6 je stále nejslibnějším oximem pro terapii akutní otravy cyklosarinem. (cs)
  • Due to their therapeutic efficacy, both newly developed K oximes can be considered to be promising oximes for the antidotal treatment of acute tabun poisonings, while the oxime HI-6 is still the most promising oxime for the treatment of acute cyclosarin poisonings
  • Due to their therapeutic efficacy, both newly developed K oximes can be considered to be promising oximes for the antidotal treatment of acute tabun poisonings, while the oxime HI-6 is still the most promising oxime for the treatment of acute cyclosarin poisonings (en)
Title
  • A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice
  • A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice (en)
  • Srovnání schopnosti nově vyvinutých oximů (K074, K075) a v současnosti používaných oximů (obidoxim, trimedoxim, HI-6) zabránit akutním toxickým účinkům tabunu a cyklosarinu u myší (cs)
skos:prefLabel
  • A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice
  • A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice (en)
  • Srovnání schopnosti nově vyvinutých oximů (K074, K075) a v současnosti používaných oximů (obidoxim, trimedoxim, HI-6) zabránit akutním toxickým účinkům tabunu a cyklosarinu u myší (cs)
skos:notation
  • RIV/60162694:G44__/08:00001945!RIV09-MO0-G44_____
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • Z(MO0FVZ0000501)
http://linked.open...iv/cisloPeriodika
  • 1
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 354113
http://linked.open...ai/riv/idVysledku
  • RIV/60162694:G44__/08:00001945
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • tabun; cyclosarin; oximes; atropine; acute toxicity; mice (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [EEF41A0A062F]
http://linked.open...i/riv/nazevZdroje
  • Drug and Chemical Toxicology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 31
http://linked.open...iv/tvurceVysledku
  • Kassa, Jiří
  • Humlíček, Vojtěch
http://linked.open...ain/vavai/riv/wos
  • 000252323200009
http://linked.open...n/vavai/riv/zamer
issn
  • 0148-0545
number of pages
http://localhost/t...ganizacniJednotka
  • G44
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 24 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software